Back to URGN
STATE STREET CORP URGN Position History
UroGen Pharma Ltd. • Healthcare
Quarters held
12
Latest value
$36.9M
Q2 2026
Peak value
$36.9M
First seen
Q4 2023
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2023 | $7.4M |
| Q1 2024 | $8.1M |
| Q2 2024 | $12.2M |
| Q3 2024 | $9.8M |
| Q4 2024 | $8.6M |
| Q1 2025 | $8.8M |
| Q2 2025 | $11.1M |
| Q3 2025 | $16.3M |
| Q4 2025 | $18.9M |
| Q1 2026 | $15.7M |
| Q2 2026 | $36.9M |
| Q2 2026 | $36.9M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $36.9M | 1.00M | — | — |
| Q2 2026 | $36.9M | 1.00M | — | — |
| Q1 2026 | $15.7M | 874.2K | — | — |
| Q4 2025 | $18.9M | 807.4K | — | — |
| Q3 2025 | $16.3M | 819.4K | — | — |
| Q2 2025 | $11.1M | 807.6K | — | — |
| Q1 2025 | $8.8M | 795.0K | — | — |
| Q4 2024 | $8.6M | 808.1K | — | — |
| Q3 2024 | $9.8M | 769.6K | — | — |
| Q2 2024 | $12.2M | 726.7K | — | — |
| Q1 2024 | $8.1M | 537.0K | — | — |
| Q4 2023 | $7.4M | 490.8K | — | — |
Other funds holding URGN
$93.6M
$57M
$57M
$48M
$48M
$45M